Section Arrow
Quote
BPTH.OOTC
- Bio-Path Holdings, Inc.
Quotes are at least 15-min delayed:2025/07/03 06:21 EDT
Last
 0.17475
-0.00025 (-0.14%)
Day High 
0.175 
Prev. Close
0.175 
1-M High
0.2316 
Volume 
29.61K 
Bid
--
Ask
--
Day Low
0.1605 
Open
0.175 
1-M Low
0.1555 
Market Cap 
1.45M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.18 
20-SMA 0.19 
50-SMA 0.17 
52-W High 3.39 
52-W Low 0.12 
Exchange OOTC 
Valuation Estimation
EPS (Current/Estimated)
0.36/-1.42
Enterprise Value
1.45M
Balance Sheet
Book Value Per Share
-0.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
No related information.
Quotes are at least 15-min delayed：2025/07/03 06:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition forany gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.